Georg Kralidis Selected Research

darifenacin

9/2005	Treatment of overactive bladder in the older patient: pooled analysis of three phase III studies of darifenacin, an M3 selective receptor antagonist.
5/2005	A pooled analysis of three phase III studies to investigate the efficacy, tolerability and safety of darifenacin, a muscarinic M3 selective receptor antagonist, in the treatment of overactive bladder.
3/2005	An investigation of dose titration with darifenacin, an M3-selective receptor antagonist.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Georg Kralidis Research Topics

Disease

3	Overactive Urinary Bladder (Overactive Bladder) 09/2005 - 03/2005
2	Cancer Pain 01/2019 - 01/2019
2	Neoplasms (Cancer) 01/2019 - 01/2019
2	Urge Urinary Incontinence (Urge Incontinence) 09/2005 - 05/2005
2	Constipation 05/2005 - 03/2005
1	Pain (Aches) 01/2019
1	Chronic Pain 01/2019
1	Infections 01/2016
1	Heart Failure 01/2016
1	Candidiasis (Moniliasis) 01/2016

Drug/Important Bio-Agent (IBA)

3	darifenacin FDA Link 09/2005 - 03/2005
2	Analgesics (Analgesic Drugs)IBA 01/2019 - 01/2019
2	6'- fluoro- 4',9'- dihydro- N,N- dimethyl- 4- phenylspiro(cyclohexane- 1,1'(3'H)- pyrano(3,4- b)indol)- 4- amineIBA 01/2019 - 01/2019
2	Pharmaceutical PreparationsIBA 01/2019 - 01/2019
2	Morphine (MS Contin)FDA LinkGeneric 01/2019 - 01/2019
1	Opioid Analgesics (Opioids)IBA 01/2019
1	TabletsIBA 01/2019
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2016
1	Cholinergic Agents (Cholinergics)IBA 05/2005

Therapy/Procedure

1	Polypharmacy 01/2019
1	Heart-Assist Devices 01/2016
1	Heart Transplantation (Grafting, Heart) 01/2016